We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
-10.48%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$720M
AUM Growth
-$79.5M
Cap. Flow
+$5.92M
Cap. Flow %
0.82%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
2
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$5.89M
2
LCTX icon
Lineage Cell Therapeutics
LCTX
+$25.4K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 47.47%
2 Consumer Staples 37.71%
3 Miscellaneous 8.82%
4 Industrials 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.13B
$279M 38.8%
10,840,630
– –
MNST icon
2
Monster Beverage
MNST
$87.7B
$272M 37.71%
18,717,232
– –
IWM icon
3
iShares Russell 2000 ETF
IWM
$77.2B
$63.6M 8.82%
420,000
– –
AXON
4
Axon Enterprise
AXON
$38.4B
$43.2M 5.99%
760,062
– –
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$263M
$33.3M 4.63%
34,005,379
+24,553
+0.1% +$25.4K
IMDX
6
Insight Molecular Diagnostics
IMDX
$125M
$23.3M 3.24%
554,913
+150,000
+37% +$5.89M
SER icon
7
Serina Therapeutics
SER
$58.2M
$5.87M 0.82%
85,219
– –

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.91B AUM 19.99% 1-Year Est. Return
RMA
Roffman Miller Associates Philadelphia, Pennsylvania $1.91B AUM 28.29% 1-Year Est. Return
LWMT
Legacy Wealth Management (Tennessee) Memphis, Tennessee $1.91B AUM 17.42% 1-Year Est. Return
FIB
First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return
HPC
Hill Path Capital New York $1.92B AUM 5.67% 1-Year Est. Return
R
Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Broadwood Capital's Q3 2019 Portfolio in Review

As of Q3 2019, Broadwood Capital held 7 positions worth $720M, down 9.9% from $800M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 48% a quarter earlier, followed by Consumer Staples and Miscellaneous.

  • Broadwood Capital added most to Insight Molecular Diagnostics in Q3 2019, an estimated $5.89M increase.
  • Broadwood Capital's ten largest holdings make up 100% of its $720M portfolio in Q3 2019.
  • Broadwood Capital opened 0 new positions and closed 0 in Q3 2019.
  • Broadwood Capital's portfolio value fell 9.9% quarter-over-quarter to $720M.

Based on Broadwood Capital's 13F filing for Q3 2019, filed 14 Nov 2019.